Brixadi Coupons & Prices

Brixadi FAQs

How much does Brixadi cost without insurance?

Without insurance, the price of Brixadi can vary, as it’s not available for purchase in retail pharmacies and is typically given in a clinic or hospital. The average cost per month is $2,351.47 for 1, 128mg/0.36ml, 1ml syringe syringe kit. To help manage these costs, SingleCare offers a discount card that may help reduce the price to as low as $1,738.66 for 1, 128mg/0.36ml, 1ml syringe syringe kit.

How much does Brixadi cost with insurance?

The cost of Brixadi with insurance can vary greatly depending on the details of your insurance plan. If a healthcare professional administers Brixadi in a clinic or healthcare facility, it may be billed under medical benefits as part of the healthcare visit. This would typically be part of the coverage for outpatient services, which can include treatments received in a healthcare provider's office or clinic. However, there may still be a copay or deductible.

Does Medicare cover Brixadi and how much does it cost?

Medicare coverage for Brixadi depends on your specific Medicare plan. Coverage would typically fall under Medicare Part B if it is administered in an outpatient setting like a health clinic. To find out if your plan covers Brixadi, check with your plan directly. Even with Medicare, SingleCare's Brixadi coupons could offer a lower price, sometimes saving you more than your Medicare plan. The lowest price available with a SingleCare coupon can be $1,738.66 for 1, 128mg/0.36ml, 1ml syringe syringe kit.

What is Brixadi? 

Brixadi is a medication approved by the FDA to treat severe opioid use disorder. It is intended for those who have already begun treatment with a transmucosal buprenorphine-containing product and need a long-term medication to prevent relapse.

As an opioid partial agonist, Brixadi helps to alleviate cravings and withdrawal symptoms without producing the full opioid effect. Brixadi works by binding to the same receptors in the brain as other opioids but does not fully activate these receptors, which can help reduce the risk of misuse. It is part of a class of drugs known as partial opioid agonists.

Is there a generic of Brixadi?

Currently, no generic version of Brixadi is available. Brixadi is a brand-name medication manufactured by Braeburn, Inc. Since it's a brand-name drug, the cost might be higher than generic medications. However, the Brixadi copay savings program and SingleCare discount cards may help patients save on their prescriptions.

What are the side effects of Brixadi?

Most medications have side effects, and Brixadi is no exception. Common side effects may include:

• Headache

• Nausea

• Constipation

• Injection site reactions

• Urinary tract infection

Serious side effects can occur, including adrenal insufficiency, a life-threatening allergic reaction, and liver problems. Brixadi also carries a boxed warning for the risk of serious harm or death if injected intravenously. Therefore, Brixadi is only available through a special REMS program (Risk Evaluation and Mitigation Strategy), which ensures that the benefits of the drug outweigh its risks, 

If you experience any severe side effects or signs of an opioid overdose, seek medical help immediately. Always consult your healthcare provider for medical advice and discuss any concerns or questions regarding your treatment plan and potential side effects. The medication guide and full prescribing information may also provide a comprehensive list of potential side effects.

How is [drug] administered?

Brixadi is administered as a subcutaneous injection by a healthcare professional. This means it is injected under the skin, typically in the abdominal area. The extended-release formulation allows for monthly or weekly dosing, which can be more convenient than daily medications. It's important that Brixadi is only administered by a healthcare provider who is enrolled in the REMS (Risk Evaluation and Mitigation Strategy) program, which ensures the safe use of certain medications that can have serious risks.

Is Brixadi a controlled substance?

Yes, Brixadi is classified as a Schedule III controlled substance. This means that while it has an accepted medical use, it also has the potential for abuse and dependence. Due to this, the handling, prescribing, and dispensing of Brixadi are subject to strict regulations to prevent misuse and diversion.

What is the difference between Brixadi and Sublocade?

Both Brixadi and Sublocade are brand-name buprenorphine products used to treat severe opioid use disorder. The main difference lies in their formulations and dosing schedules. Brixadi can be given as a weekly or monthly extended-release injection, while Sublocade is only recommended as a monthly injection. Additionally, Brixadi may be administered in various locations such as the buttock, thigh, stomach, or upper arm, whereas Sublocade is only injected into the abdomen.